New Delhi [India], January 3 (ANI): Prime Minister Narendra Modi congratulated the country as Drugs Controller General of India (DCGI) granted emergency use approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines on Sunday.
New Delhi [India], January 3 (ANI): The Drugs Controller General of India will brief the media at 11 am today at the National Media Centre regarding the coronavirus vaccine.
New Delhi [India], January 2 (ANI): Prime Minister Narendra Modi has received the highest approval rating of 55 per cent among top world leaders in the survey conducted by an American research firm, Information and Broadcasting Minister Prakash Javadekar said on Saturday.
New Delhi [India], January 2 (ANI): Various editions of Urdu publications have carried the prominent news that the Subject Expert Committee of Drugs Controller General of India (DCGI) has recommended granting permission for Emergency Use Authorisation (EUA) with certain conditions to COVID-1
New Delhi [India], January 1 (ANI) In a major development related to the COVID vaccine, the Subject Expert Committee of Drugs Controller General of India (DCGI) has recommended granting permission for Emergency Use Authorisation (EUA)with certain conditions to COVID-19 vaccine being manufact
New Delhi [India], December 30 (ANI): Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a "big step forward", AIIMS Delhi Director Dr Randeep Guleria on Wednesday said that India will have the COVID-19 vaccine within days.
New Delhi [India], December 30 (ANI): Subject Expert Committee (SEC) of Drugs Controller of India will take a meeting to consider Serum Institute of India's application for emergency use approval of its COVID-19 vaccine, says a government official.
New Delhi [India], December 29 (ANI): Union Health Minister Dr Harsh Vardhan On Monday inaugurated India's first pneumococcal conjugate vaccine "Pneumosil", which has been developed by the Serum Institute of India Private Limited (SIIPL) in collaboration with partners like the Bill and Melin
Pune (Maharashtra) [India], December 28 (ANI): Serum Institute of India, the largest vaccine manufacturer in the world by doses, announces the launch of India's first indigenously developed pneumococcal vaccine - PNEUMOSIL.
Pune (Maharashtra) [India], December 28 (ANI): In what could be termed as New Year gift, Adar Poonawalla, Chief Executive Officer, Serum Institute of India on Monday said 40-50 million doses of COVID-19 vaccine have already been stockpiled, adding that Covishield rollout is expected in Ja
New Delhi[India], December 9 (ANI): In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines
New Delhi [India], December 7 (ANI): Delhi Lieutenant Governor Anil Baijal on Monday chaired a meeting with Principal Secretary (Health) and Directorate General of Health Services (DGHS) and additional director of Serum Institute of India (SII) to review preparedness for COVID-19 vaccination